Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb 21;20(7):1768-76.
doi: 10.3748/wjg.v20.i7.1768.

Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease

Affiliations
Review

Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease

Xue-Qun Zhang et al. World J Gastroenterol. .

Abstract

Nonalcoholic fatty liver disease (NAFLD) has emerged as a common public health problem in recent decades. However, the underlying mechanisms leading to the development of NAFLD are not fully understood. The endoplasmic reticulum (ER) stress response has recently been proposed to play a crucial role in both the development of steatosis and progression to nonalcoholic steatohepatitis. ER stress is activated to regulate protein synthesis and restore homeostatic equilibrium when the cell is stressed due to the accumulation of unfolded or misfolded proteins. However, delayed or insufficient responses to ER stress may turn physiological mechanisms into pathological consequences, including fat accumulation, insulin resistance, inflammation, and apoptosis, all of which play important roles in the pathogenesis of NAFLD. Therefore, understanding the role of ER stress in the pathogenesis of NAFLD has become a topic of intense investigation. This review highlights the recent findings linking ER stress signaling pathways to the pathogenesis of NAFLD.

Keywords: Endoplasmic reticulum stress; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Unfolded protein response.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The unfolded protein response pathway. When the unfolded protein response is activated, the first event is the dissociation of the chaperone Bip from the three integral proteins PERK, IRE1, and ATF6, leading to their activation. When activated, PERK phosphorylates and inhibits eiF2α, leading to a global decrease in protein translation. Moreover, p-eiF2α activates ATF4, which induces the expression of several genes, including amino acid transporters, chaperones, and CHOP. Activation of IRE1 promotes the splicing of XBP1 mRNA and the subsequent transcription of molecular chaperones and genes involved in ERAD. Finally, activated ATF6 undergoes proteolytic cleavage in the Golgi, transactivating genes such as endoplasmic reticulum (ER) chaperones and foldases. Bip: Binding immunoglobulin protein; ATF6: Activating transcription factor-6; IRE1: Inositol requiring enzyme-1; PERK: Protein kinase RNA-like ER kinase; XBP1: X-box-binding protein-1; eiF2α: Eukaryotic translation initiation factor 2α; ATF4: Transcription factor 4; ERAD: Endoplasmic reticulum associated protein degradation; CHOP: C/EBP-homologous protein.
Figure 2
Figure 2
Roles of endoplasmic reticulum stress in the development of steatosis and progression to nonalcoholic steatohepatitis. ER stress interferes with hepatic lipid metabolism by activating lipogenesis and limiting VLDL formation and secretion. ER stress also acts indirectly on liver triglyceride accumulation by promoting insulin resistance in both the liver and adipose tissue. Furthermore, ER stress promotes the activation of Nrf2, JNK, NF-κB, CREBH, and CHOP, which actively participate in the inflammatory process and cell death. ER: Endoplasmic reticulum; VLDL: Very-low-density lipoprotein; Nrf2: Nuclear factor-erythroid-derived 2-related factor 2; JNK: c-Jun N-terminal kinase; NF-κB: Nuclear factor-κB; CREBH: Cyclic-AMP responsive element-binding protein H; CHOP: C/EBP-homologous protein; TRAF: Tumor-necrosis factor α-receptor-associated factor; TG: Triglyceride.

Similar articles

Cited by

References

    1. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–131. - PubMed
    1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–285. - PubMed
    1. Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol. 2013;28 Suppl 1:11–17. - PubMed
    1. Farrell GC, Wong VW, Chitturi S. NAFLD in Asia--as common and important as in the West. Nat Rev Gastroenterol Hepatol. 2013;10:307–318. - PubMed
    1. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419. - PubMed

Publication types